COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 2605: Articles 26041-26050  | Next

The effect of serological screening for SARS-CoV-2 antibodies to participants' attitudes and risk behaviour: a study on a tested population sample of industry workers in Split-Dalmatia County, Croatia
Ljubic, T., Banovac, A., Buljan, I., Jerkovic, I., Basic, Z., Kruzic, I., Kolic, A., Kolombatovic, R. R., Marusic, A., Andjelinovic, S.
10.1101/2020.06.15.20131482 — Posted: 2020-06-17
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
Lu, J., Peng, J., Xiong, Q., Liu, Z., Lin, H., Tan, X., Kang, M., Yuan, R., Zeng, L., Zhou, P., Liang, C., Yi, L., Plessis, L. d., Song, T., Ma, W., Sun, J., Pybus, O., Ke, C.
10.1101/2020.06.15.20131748 — Posted: 2020-06-17
Early impacts of the COVID-19 pandemic on mental health care and on people with mental health conditions: framework synthesis of international experiences and responses
Sheridan Rains, L., Johnson, S., Barnett, P., Steare, T., Needle, J. J., Carr, S., Lever Taylor, B., Bentivegna, F., Edbrooke-Childs, J., Scott, H. R., Rees, J., Shah, P., Lomani, J., Chipp, B., Barber, N., Dedat, Z., Oram, S., Morant, N., Simpson, A., COVID-19 Mental Health Policy Research Unit Group
10.1101/2020.06.15.20129411 — Posted: 2020-06-17 Discussion: Onsite
Risk of Depression in Family Caregivers: Unintended Consequence of COVID-19
Gallagher, S., Wetherell, M.
10.1101/2020.06.15.20131532 — Posted: 2020-06-17
Causes of Death and Comorbidities in Patients with COVID-19
Elezkurtaj, S., Greuel, S., Ihlow, J., Michaelis, E., Bischoff, P., Kunze, C. A., Sinn, B. V., Gerhold, M., Hauptmann, K., Ingold-Heppner, B., Miller, F., Herbst, H., Corman, V. M., Martin, H., Heppner, F. L., Horst, D.
10.1101/2020.06.15.20131540 — Posted: 2020-06-17 Discussion: Onsite
A compound Dirichlet-Multinomial model for provincial level Covid-19 predictions in South Africa
De Waal, A., De Waal, D.
10.1101/2020.06.15.20131433 — Posted: 2020-06-17
Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera
Stroemer, A., Grobe, O., Rose, R., Fickenscher, H., Lorentz, T., Krumbholz, A.
10.1101/2020.06.15.20131672 — Posted: 2020-06-17
Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets
Reps, J. M., Kim, C., Williams, R. D., Markus, A. F., Yang, C., Salles, T. D., Falconer, T., Jonnagaddala, J., Williams, A., Fernandez-Bertolin, S., DuVall, S. L., Kostka, K., Rao, G., Shoaibi, A., Ostropolets, A., Spotnitz, M. E., Zhang, L., Casajust, P., Steyerberg, E., Nyberg, F., Kaas-Hansen, B. S., Choi, Y. H., Morales, D., Liaw, S.-T., Abrahao, M. T. F., Areia, C., Matheny, M. E., Aragon, M., Park, R. W., Hripcsak, G., Reich, C. G., Suchard, M. A., You, S. C., Ryan, P. B., Prieto-Alhambra, D., Rijnbeek, P. R.
10.1101/2020.06.15.20130328 — Posted: 2020-06-17
in-silica Analysis of SARS-CoV-2 viral strain using Reverse Vaccinology Approach: A Case Study for USA
Agarwal, A.
10.1101/2020.06.16.154559 — Posted: 2020-06-17
Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp
Eskier, D., Suner, A., Karakulah, G., Oktay, Y.
10.1101/2020.06.15.153239 — Posted: 2020-06-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).